DUNN GORDON (Chief Financial Officer) purchased 423.6% of their position (122.22K shares) of QUOIN PHARMACEUTICALS, LTD. on the open market
Open‑market purchase worth $55.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/27/2024ACC: 0001104659-24-132187
Officer· Chief Financial Officer
Since Jan 2023
+366.66K
Net shares
Net buyer
$55.0K
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
366.66K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+122.22K
Price / share
$0.45
Trade value
$55K
% of position
423.6%
12/23/2024
28.86K→151.08K
Total
Net shares
+122.22K
Net value
$55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 12/23/2024 | P · Purchase | +122.22K | $0.45 | $55K | 423.6% | 28.86K | 151.08K |
| Total | +122.22K | $55K | ||||||
Derivative Transactions2
Series F Warrants (right to buy)
Direct
Converts to
ADS
122.22K shares
Shares
+122.22K
Strike price
0.45
Held after
122.22K
Exercisable
—
12/23/2024
Series G Warrants (right to buy)
Direct
Converts to
ADS
122.22K shares
Shares
+122.22K
Strike price
0.45
Held after
122.22K
Exercisable
—
12/23/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series F Warrants (right to buy) Direct | ADS122.22K shares | 12/23/2024 | P · Purchase | +122.22K | 0.45 | — | 122.22K |
| Series G Warrants (right to buy) Direct | ADS122.22K shares | 12/23/2024 | P · Purchase | +122.22K | 0.45 | — | 122.22K |